Showing results (5651-5660 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|December 8, 2004
Progress in the development of melanocortin receptor selective ligandsBoman G Irani, Jerry R Holder, Aleksandar Todorovic, et al.Current Pharmaceutical Design|December 8, 2004
Recent progress in work on PGD2 antagonists for drugs targeting allergic diseasesSusumu MitsumoriCurrent Pharmaceutical Design|December 8, 2004
Combination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary diseaseDon D Sin, Malcolm Johnson, Wen Qi Gan, et al.Current Pharmaceutical Design|December 8, 2004
Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertensionMichael D Sosin, Gurbir S Bhatia, Gregory Y H Lip, et al.Current Pharmaceutical Design|December 8, 2004
Hypertension in peripheral arterial diseaseDenis L Clement, Marc L De Buyzere, Daniel A DuprezCurrent Pharmaceutical Design|December 8, 2004
Common structural stability properties of 4-helical bundle cytokines: possible physiological and pharmaceutical consequencesMargaret Speed Ricci, David N BremsCurrent Pharmaceutical Design|December 8, 2004
Cellular physiology of mismatch repairX Wu, Z Khalpey, M CascalhoCurrent Pharmaceutical Design|April 14, 2006
Hereditary Haemorrhagic Telangiectasia (HHT): genetic and molecular aspectsG M Lenato, G GuantiCurrent Pharmaceutical Design|April 14, 2006
Hereditary haemorrhagic teleangiectasia: diagnostic imaging of visceral involvementMaurizio Memeo, Arnaldo Scardapane, Amato Antonio Stabile Ianora, et al.Current Pharmaceutical Design|April 14, 2006
Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by hereditary haemorrhagic teleangiectasiaE De Cillis, N Burdi, A S Bortone, et al.Pageof 1,008